News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,841 Results
Type
Article (41519)
Company Profile (301)
Press Release (657021)
Section
Business (206692)
Career Advice (2057)
Deals (35798)
Drug Delivery (92)
Drug Development (81444)
Employer Resources (169)
FDA (16285)
Job Trends (15104)
News (349224)
Policy (33124)
Tag
Academia (2616)
Alliances (50194)
Alzheimer's disease (1275)
Approvals (16251)
Artificial intelligence (150)
Bankruptcy (356)
Best Places to Work (11684)
Biotechnology (209)
Breast cancer (190)
Cancer (1388)
Cardiovascular disease (112)
Career advice (1718)
Cell therapy (284)
Clinical research (65086)
Collaboration (490)
Compensation (264)
COVID-19 (2607)
C-suite (111)
Data (1402)
Diabetes (178)
Diagnostics (6345)
Earnings (85448)
Employer resources (147)
Events (110974)
Executive appointments (401)
FDA (16983)
Funding (443)
Gene therapy (199)
GLP-1 (610)
Government (4389)
Healthcare (18869)
Infectious disease (2701)
Inflammatory bowel disease (112)
Interviews (315)
IPO (16438)
Job creations (3825)
Job search strategy (1467)
Layoffs (426)
Legal (8087)
Lung cancer (203)
Manufacturing (208)
Medical device (13299)
Medtech (13304)
Mergers & acquisitions (19536)
Metabolic disorders (464)
Neuroscience (1599)
NextGen Class of 2024 (6562)
Non-profit (4530)
Northern California (1713)
Obesity (263)
Opinion (193)
Parkinson's disease (98)
Patents (122)
People (57341)
Phase I (20247)
Phase II (28615)
Phase III (21385)
Pipeline (516)
Postmarket research (2614)
Preclinical (8669)
Radiopharmaceuticals (237)
Rare diseases (265)
Real estate (6138)
Regulatory (22099)
Research institute (2381)
Resumes & cover letters (359)
Southern California (1481)
Startups (3619)
United States (15389)
Vaccines (578)
Weight loss (183)
Date
Today (32)
Last 7 days (82)
Last 30 days (2066)
Last 365 days (35443)
2024 (35443)
2023 (40366)
2022 (51478)
2021 (56086)
2020 (54548)
2019 (47058)
2018 (35411)
2017 (32601)
2016 (32076)
2015 (38092)
2014 (32004)
2013 (27149)
2012 (29221)
2011 (29926)
2010 (27991)
Location
Africa (747)
Arizona (198)
Asia (38318)
Australia (6289)
California (3871)
Canada (1466)
China (315)
Colorado (175)
Connecticut (179)
Europe (82855)
Florida (538)
Georgia (137)
Illinois (391)
Indiana (227)
Maryland (644)
Massachusetts (2987)
Michigan (175)
Minnesota (297)
New Jersey (1121)
New York (1102)
North Carolina (760)
Northern California (1713)
Ohio (147)
Pennsylvania (935)
South America (1130)
Southern California (1481)
Texas (562)
Utah (110)
Washington State (404)
698,841 Results for "upsher smith laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
UPSHER-SMITH LAUNCHES METHIMAZOLE TABLETS, USP
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately $36.8 million for the 12 months ending December 2023 according to IQVIA.
March 29, 2024
·
1 min read
BioMidwest
UPSHER-SMITH PREVIEWS EXPANSION OF ITS RARE DISEASE PORTFOLIO AT 2024 AAN ANNUAL MEETING
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be participating in the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, from April 13 to 18, 2024.
April 12, 2024
·
8 min read
Press Releases
UPSHER-SMITH TO FEATURE MULTIPLE PRESENTATIONS AT THE AMERICAN EPILEPSY SOCIETY (AES) 2024 ANNUAL MEETING
December 3, 2024
·
14 min read
BioMidwest
UPSHER-SMITH LAUNCHES PITAVASTATIN TABLETS
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Pitavastatin Tablets in 1 mg, 2 mg, and 4 mg strengths.
November 6, 2023
·
1 min read
Press Releases
UPSHER-SMITH PRESENTS EXPANDED RARE DISEASE PORTFOLIO AT 2024 CHILD NEUROLOGY SOCIETY ANNUAL MEETING
November 12, 2024
·
20 min read
Drug Development
Upsher-Smith Laboratories, LLC Selects PANTHERx® Rare for the Distribution of TORPENZ™ (everolimus) Tablets
August 20, 2024
·
9 min read
BioMidwest
Upsher-Smith and the National Alliance of State Pharmacy Associations (NASPA) Announce Excellence in Innovation Award Recipients
Upsher-Smith Laboratories, LLC and the National Alliance of State Pharmacy Associations proudly announce the recipients of the 2023 NASPA Excellence in Innovation Award.
February 6, 2024
·
3 min read
Deals
CDMO Bora Pharmaceuticals Buys Generics Manufacturer Upsher-Smith for $210M
Taiwanese contract development and manufacturing organization Bora will purchase Minnesota-based Upsher-Smith Laboratories, expanding operations into the U.S. for the first time.
January 18, 2024
·
2 min read
·
Tyler Patchen
BioMidwest
UPSHER-SMITH LAUNCHES FAMOTIDINE FOR ORAL SUSPENSION, USP
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Famotidine for Oral Suspension, USP.
August 15, 2023
·
1 min read
BioMidwest
UPSHER-SMITH LAUNCHES ISOTRETINOIN CAPSULES, USP
Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Isotretinoin Capsules, USP in 10 mg, 20 mg, 30 mg, and 40 mg strengths.
July 24, 2023
·
3 min read
1 of 69,885
Next
